Latest news
MHRA awards Innovation Passports to liver cancer and dementia medicines - PharmafilePharmafile · Fri, 07 Aug 2026 10:24:41 GMTUK ILAP Grants Innovation Passports to BeOne's Liver Cancer Therapy & CervoMed's Dementia Candidate - NAVLIN DAILYNAVLIN DAILY · Fri, 07 Aug 2026 08:42:41 GMTPadsPass Awarded "Pet Start Up of the Year" In 2026 Pet Innovation Awards Program - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 13:30:00 GMTCervoMed granted Innovation Passport for neflamapimod in UK - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 13:17:34 GMTInnovation Passports for Liver Cancer and Dementia Treatm... - politicsuk.compoliticsuk.com · Wed, 05 Aug 2026 08:04:23 GMTCervoMed granted UK Innovation Passport for neflamapimod in dementia with Lewy bodies - TradingViewTradingView · Tue, 04 Aug 2026 11:53:00 GMTHope for Dementia with Lewy Bodies as New Treatment Wins Fast-Track Regulatory Backing - thecareruk.comthecareruk.com · Tue, 04 Aug 2026 10:42:02 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:15:00 GMT